Posted On: 08/14/2013 5:42:58 PM
Post# of 63824
Afternoon Pharma PRs
- Axxess Pharma Inc. Announces Two-Time Canadian Heavyweight Boxing Champion Ray Olubowale as Spokesperson and Corporate Ambassador
5:31 pm - Marketwire - LabCorp Applauds National Kidney Foundation’s Guidance about Testing for Chronic Kidney Disease; LabCorp’s CKD Program Provides Clinically Significant Data to Assist Diagnosis and Treatment
5:10 pm - Business Wire - ProMetic Reports Its Second Quarter 2013 Highlights and Financial Results
5:00 pm - Marketwire - ProMetic annonce les faits saillants et les résultats financiers de son second trimestre de 2013
5:00 pm - Marketwire - ProMetic Reports Its Second Quarter 2013 Highlights and Financial Results
5:00 pm - Marketwire - Urologix to Host Its Fourth Quarter and Full Fiscal Year 2013 Conference Call
5:00 pm - GlobeNewswire - QEVLAR Quiz App, is this the answer to interactive training for medical imaging students?
4:58 pm - PR Newswire - Androforte - A Superior Form of Androgel Low Testosterone Supplement - Now Available at Discount Prices from TestoMeds
4:54 pm - PR Newswire - Titan Pharmaceuticals Announces Second Quarter 2013 Financial Results
4:51 pm - Marketwire - Covis Pharma Holdings S.a.r.l. Appoints Dean J. Mitchell As Executive Chairman of the Board
4:43 pm - PR Newswire - FDA Approves Epaned, a Liquid Form of Enalapril for Children and Adults
4:40 pm - PR Newswire - Atrion Corporation Increases Quarterly Cash Dividend by 14%
4:30 pm - Marketwire - Aeolus Announces Third Quarter Fiscal Year 2013 Financial Results
4:30 pm - Marketwire - SANUWAVE Reports Second Quarter 2013 Financial Results
4:30 pm - GlobeNewswire - Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2014
4:29 pm - GlobeNewswire - At the Beverly Hills Hernia Center, the Focus is on Tailoring Treatment to Individual Patients
4:24 pm - PR Newswire - Interleukin Genetics Reports Second Quarter 2013 Financial Results
4:20 pm - Business Wire - NxThera Announces Series C Financing & CE Mark
4:16 pm - Business Wire - bluebird bio Reports Fiscal Second Quarter 2013 Financial Results
4:05 pm - Business Wire - PLC Systems Reports Second Quarter 2013 Financial Results
4:05 pm - Marketwire - Hyperion Therapeutics Announces Second Quarter 2013 Financial Results
4:05 pm - GlobeNewswire - Tengion Provides Business Update and Reports Second Quarter 2013 Financial Results
4:05 pm - PR Newswire - Guided Therapeutics Reports Second Quarter 2013 Results
4:05 pm - Business Wire - Forest Laboratories and Almirall Decide to Delay NDA Filing for Aclidinium/formoterol Combination
4:02 pm - Business Wire - Vermillion Reports Second Quarter 2013 Results
4:01 pm - PR Newswire - AdCare Health Systems Reports Second Quarter 2013 Results
4:01 pm - PR Newswire - Atossa Genetics Reports Second Quarter 2013 Results and Operating Highlights
4:01 pm - Marketwire - Cyclacel Reports Second Quarter 2013 Financial Results
4:01 pm - GlobeNewswire - Symmetry Technologies Inc. acquires the rights to a ground breaking technology that produces Biosynthetic Testosterone in men from A Houston PhD led Biomedical research firm. Technology estimated value up to 10 Billion Dollars.
4:00 pm - GlobeNewswire - Galectin Therapeutics Reports Second Quarter 2013 Financial Results
4:00 pm - GlobeNewswire - Intergraph(R) CADWorx(R) & Analysis University Express on September 12th in Amsterdam to Provide Training on CADWorx, CAESAR II(R), and PV Elite(R)
3:48 pm - Marketwire - Leading Proxy Advisory Firms Recommend Vote in Favor of All Proposals for Teva Pharmaceutical's Annual Meeting
3:46 pm - Business Wire - Bright Side Dental Opens Office in Clarkston
3:29 pm - Marketwire - BIOLASE to Reduce Total Offering on Form S-3 From $30 Million to $5 Million
3:28 pm - Marketwire - How A Little Girl With Brain Cancer Inspired 'Citizen Science'
3:06 pm - PR Newswire - Family of six killed by police pursuit devastates members of national nonprofit organization
3:00 pm - GlobeNewswire - Skystar Bio-Pharmaceutical Reports Second Quarter 2013 Results
3:00 pm - Marketwire - Bavituximab's Mechanism of Action Highlighted at Immunomodulatory Therapeutic Antibodies for Cancer Conference
3:00 pm - Marketwire - Natus Neurology Incorporated Receives 510(k) & Health Canada Clearance And Launches New Electrodiagnostic System In U.S. & Canada
2:59 pm - PR Newswire - Research and Markets: Alexion Pharmaceuticals Partnering 2005-2013 Study Contains Deals Listed by Deal Type, Stage of Development and Therapy Focus, Allowing Easy Access
2:29 pm - Business Wire - Research and Markets: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2012
2:11 pm - Business Wire - PuraMed BioScience Announces Distributor Agreement with OuterBanks Outdoors
2:08 pm - PR Newswire - Research and Markets: Global Urological Catheters (Dialysis & Urinary) Strategic Business Report 2013-2018: Urinary Catheters Take the Lead
2:08 pm - Business Wire - Plastic Surgeon Releases Guidelines to Great Facelifts
2:03 pm - Marketwire - Research and Markets: Global Electrophoresis Equipment Market 2012-2016 with Bio-Rad Laboratories Inc., GE Healthcare Ltd. and Hoefer Inc. Dominating
2:03 pm - Business Wire - CORRECTING and REPLACING SAGE Therapeutics Appoints Biotech Industry Veteran Dr. Jeffrey Jonas to Chief Executive Officer; Expands Leadership Team with Two Key Appointments
2:03 pm - Business Wire - LeMaitre Vascular to Present at the Three Part Advisors Midwest IDEAS Investor Conference on Tuesday, August 27, 2013
2:01 pm - GlobeNewswire - Canadian Association Of Internes And Residents: Six Practical Steps To Better Health Care
2:00 pm - PR Newswire - Childhood Obesity: Are We Winning the Race?
2:00 pm - PR Newswire - DARA Reports Second Quarter 2013 Financial Results and Operational Overview
2:00 pm - Marketwire - Research and Markets: Viropharma Partnering 2005-2013 Provides an In-Depth Insight into the Partnering Interests and Activities of one of the World's Leading Biopharma Companies
1:52 pm - Business Wire - Research and Markets: Global Mammography (Analog & Digital) Equipment Report 2013-2018: The Gold Standard Technique in Breast Cancer Screening
1:48 pm - Business Wire - Global Biologic Drugs Market to Jump to Over $220 Billion by 2019
1:45 pm - Marketwire - ZELTIQ to Present at Canaccord Genuity 33rd Annual Growth Conference
1:29 pm - GlobeNewswire - Modernizing Medicine Named One of Modern Healthcare's 2013 Best Places to Work in Healthcare
1:00 pm - Marketwire - VetDC, Inc. Acquires Novel, Targeted Anti-Cancer Drug from Pathway Therapeutics, Inc.
1:00 pm - Business Wire - Algae Biomass Summit Showcases Innovation in Algae Engineering
12:53 pm - Marketwire - Research and Markets: Primary Systemic Amyloidosis - Pipeline Review, H2 2012
12:47 pm - Business Wire - Research and Markets: Vertex Partnering 2005-2013 Provides All the Information You Require To Better Understand Vertex and Its Partnering Interests and Activities over the Past Seven Years
12:46 pm - Business Wire
(0)
(0)
